⌘K
Loading ticker…
Quince Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Quince Therapeutics, Inc. Common Stock (QNCX) has a 3-month relative strength percentile of 40 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 30. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.7%, relative volume 0.63×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
40 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
QNCX is in a stage 4 downtrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -16.6% / -92.6%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | QNCX Jan avg: -9.25% median: 2.10% win: 50% σ: 63.45% n: 4 2022-08-02 → 2026-05-29 | QNCX Feb avg: -9.13% median: -7.64% win: 25% σ: 12.87% n: 4 2022-08-02 → 2026-05-29 | QNCX Mar avg: 5.53% median: -13.37% win: 25% σ: 42.07% n: 4 2022-08-02 → 2026-05-29 | QNCX Apr avg: 2.73% median: -0.49% win: 50% σ: 19.37% n: 4 2022-08-02 → 2026-05-29 | QNCX May avg: -10.51% median: -8.83% win: 0% σ: 9.01% n: 4 2022-08-02 → 2026-05-29 | QNCX Jun avg: 16.45% median: 0.33% win: 67% σ: 36.89% n: 3 2022-08-02 → 2026-05-29 (current) | QNCX Jul avg: -5.95% median: -0.01% win: 33% σ: 12.46% n: 3 2022-08-02 → 2026-05-29 | QNCX Aug avg: -4.11% median: -6.59% win: 25% σ: 9.33% n: 4 2022-08-02 → 2026-05-29 | QNCX Sep avg: -6.18% median: -6.31% win: 50% σ: 16.43% n: 4 2022-08-02 → 2026-05-29 | QNCX Oct avg: 17.95% median: -6.06% win: 50% σ: 61.44% n: 4 2022-08-02 → 2026-05-29 | QNCX Nov avg: 28.29% median: 9.12% win: 50% σ: 65.72% n: 4 2022-08-02 → 2026-05-29 | QNCX Dec avg: -3.13% median: -8.50% win: 25% σ: 14.27% n: 4 2022-08-02 → 2026-05-29 |